vanthana bharathi (@drvanthanab) 's Twitter Profile
vanthana bharathi

@drvanthanab

@mdandersonnews Leukemia Fellow

ID: 135097610

linkhttps://www.instagram.com/drvanb/ calendar_today20-04-2010 09:50:15

209 Tweet

97 Takipçi

314 Takip Edilen

Sonali Bendre Behl (@iamsonalibendre) 's Twitter Profile Photo

Five years ago, I chose Memorial Sloan Kettering Cancer Center in New York for lifesaving care from a team of oncologists and surgeons. In 2022, I was honoured to cut the ribbon with distinguished guests at MSK’s India centre in Chennai. Today, MSK serves India via a remote #secondopinion program, and

Dr. Glaucomflecken (@dglaucomflecken) 's Twitter Profile Photo

A lot of people are dragging this person. The knee jerk reaction of “92% coverage?! That’s amazing! Why are you complaining. Leave the country.” This shows how low the bar has been set for health insurance coverage in the US. Let’s put on our empathy hats for a moment. Imagine

Naveen Pemmaraju, MD (@doctorpemm) 's Twitter Profile Photo

👉👉👉FDA approves #imetelstat for low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent #anemia | ⁦U.S. FDA⁩ ⁦FDA Oncology⁩ | #MDSsm #leusm #MPNSM #TelomeraseInhibitor fda.gov/drugs/resource…

Blood Cancers Today (@blood_cancers) 's Twitter Profile Photo

📝 A study presented at #SOHO2024 investigated the therapeutic benefit associated with immune checkpoint inhibitors for the treatment of #MDS. 📰 Read more about the study by vanthana bharathi of Saint Peter's HCS. ➡️ buff.ly/3z9Q2Xw

📝 A study presented at #SOHO2024 investigated the therapeutic benefit associated with immune checkpoint inhibitors for the treatment of #MDS.

📰 Read more about the study by <a href="/drvanthanab/">vanthana bharathi</a> of <a href="/sphcs_news/">Saint Peter's HCS</a>.

➡️ buff.ly/3z9Q2Xw
AmericanJournalofHematology (@ajhematology) 's Twitter Profile Photo

#PrecisionMedicine in #AML - a review of standard and investigational lower intensity treatment options for patients with newly diagnosed AML onlinelibrary.wiley.com/doi/10.1002/aj…

#PrecisionMedicine in #AML - a review of standard and investigational lower intensity treatment options for patients with newly diagnosed AML
onlinelibrary.wiley.com/doi/10.1002/aj…
Andrés Calderón V. (@andrescaldv) 's Twitter Profile Photo

Amazing poster on the results of the Phase Ib/II study of CPX-351 plus #Venetoclax for R/R #AML, presented by vanthana bharathi. Come by poster 4272 in the poster hall starting at 5:30 pm ASH MD Anderson Cancer Center #EndCancer #Leukemia #ASH24 #SanDiego #GaslampQuarter

Amazing poster on the results of the Phase Ib/II study of CPX-351 plus #Venetoclax for R/R #AML, presented by <a href="/drvanthanab/">vanthana bharathi</a>. Come by poster 4272 in the poster hall starting at 5:30 pm <a href="/ASH_hematology/">ASH</a> <a href="/MDAndersonNews/">MD Anderson Cancer Center</a> #EndCancer #Leukemia 
#ASH24 #SanDiego #GaslampQuarter
LARVOL (@larvol) 's Twitter Profile Photo

Meet the women on X changing the face of oncology. These peer-nominated oncologists are not just socially influential but deeply inspiring. Let’s celebrate their brilliance! #LARVOL #CancerResearch #Oncology #OncologyInsights #OncologyUpdates #CancerCare #CancerData

Meet the women on X changing the face of oncology. These peer-nominated oncologists are not just socially influential but deeply inspiring. Let’s celebrate their brilliance!

#LARVOL #CancerResearch #Oncology #OncologyInsights #OncologyUpdates #CancerCare #CancerData
VJHemOnc (@vjhemonc) 's Twitter Profile Photo

It was lovely speaking with vanthana bharathi of MD Anderson Cancer Center at #ASH24 to hear the results of a Phase Ib/II study of CPX-351 plus venetoclax in patients with R/R AML. Watch here: 👉 ow.ly/Y7fX50UGK03 👈 #AMLsm #Leusm #Leukemia #CTSM #TrialUpdate #HemOnc ASH

vanthana bharathi (@drvanthanab) 's Twitter Profile Photo

The present and future of medical management of Obesity by Andrés Calderón V. Houston Methodist A Must-read! #obesity #cardiovasculardisease Medical Management of Obesity: Current Trends and Future Perspectives | Methodist DeBakey Cardiovascular J journal.houstonmethodist.org/articles/10.14…

Oriol Pich (@oriol_pich) 's Twitter Profile Photo

🚨Thrilled to share our latest work: “Tumor-Infiltrating Clonal Hematopoiesis” NEJM - we investigated how age-related blood mutations impact cancer when they infiltrate tumors, with Elsa Bernard Maria Zagorulya, Elli Papaemmanuil, PhD Charles Swanton + more nejm.org/doi/full/10.10…

Vivek Subbiah, MD (@viveksubbiah) 's Twitter Profile Photo

🚨 Wow! #ASCO25 ASCO was absolutely massive! 10 NEJM papers published simultaneously 👉 all practice-changing studies ! 🔬✨🧵 See below for these studies 👇@oncoalert

Amer Zeidan MBBS,MHS ‏عامر زيدان (@dr_amerzeidan) 's Twitter Profile Photo

Long awaited results of #VERONA (PH3 of aza-ven vs aza) in higher risk MDS press release with negative top line results for OS. We unfortunately remain in the dreaded boulevard of broken dreams in higher risk #MDSsm. Subgroup analyses will be important. news.abbvie.com/2025-06-16-Abb…

Zhuoer (Zoey) Xie, MD, MSCR (@zhuoerxie) 's Twitter Profile Photo

#FindingFunbiologyFriday The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts ashpublications.org/bloodadvances/…

Zhuoer (Zoey) Xie, MD, MSCR (@zhuoerxie) 's Twitter Profile Photo

#MolecularMonday OMG of OGM 😀 Optical Genome Mapping (OGM) in Myelodysplastic Syndromes: Clinical Value an... sciencedirect.com/science/articl…